Illumina (ILMN) Tops Q1 EPS by 3c, provides guidance

Illumina (NASDAQ: ILMN) reported Q1 EPS of $0.97, $0.03 better than the analyst estimate of $0.94. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.04 billion.

GUIDANCE:

Illumina sees FY2025 EPS of $4.20-$4.30.
Core Illumina revenue to decline between (1%) and (3%) on a constant currency basis year over year, down from low single digit growth previously

Revenue outside of the Greater China region expected to grow between 0% and 2% in 2025 on a constant currency basis year over year and includes our estimate reflecting changes in the research funding environment as well as the projected benefit from pricing actions
Reported revenue from the Greater China region expected to be $165 - $185 million in 2025 (with $72 million in revenue recognized in Q1 2025)

For earnings history and earnings-related data on Illumina (ILMN) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink